31
May
StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data
Company to Commence Orderly Wind Down of Operations…
StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data
Company to Commence Orderly Wind Down of Operations…